Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17895593rdf:typepubmed:Citationlld:pubmed
pubmed-article:17895593lifeskim:mentionsumls-concept:C0008865lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0027746lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0233794lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0596577lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0599668lld:lifeskim
pubmed-article:17895593lifeskim:mentionsumls-concept:C0062638lld:lifeskim
pubmed-article:17895593pubmed:issue1lld:pubmed
pubmed-article:17895593pubmed:dateCreated2007-9-26lld:pubmed
pubmed-article:17895593pubmed:abstractTextWe have recently reported that nobiletin, a citrus flavonoid, improves impaired memory in olfactory-bulbectomized (OBX) mice, which have been widely utilized as a useful paradigm that shares some major clinical features of Alzheimer's disease. Here, we examined the effects of nobiletin on OBX-induced cholinergic neurodegeneration in mice. OBX mice showed reduced acetylcholinesterase (AChE) staining and choline acetyltransferase (ChAT) expression in the hippocampus. An 11-day administration of nobiletin rescued OBX-induced decrease in the density of AChE-staining and ChAT expression in the hippocampus. These results suggest that nobiletin rescues OBX-induced cholinergic neurodegeneration, accompanied by improvement of impaired memory in OBX mice.lld:pubmed
pubmed-article:17895593pubmed:languageenglld:pubmed
pubmed-article:17895593pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:citationSubsetIMlld:pubmed
pubmed-article:17895593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17895593pubmed:statusMEDLINElld:pubmed
pubmed-article:17895593pubmed:monthSeplld:pubmed
pubmed-article:17895593pubmed:issn1347-8613lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:OhizumiYasush...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:MimakiYoshihi...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:SashidaYutaka...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:YokosukaAkihi...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:TadanoTakeshi...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:KatoChiekoClld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:SongSi-YoungS...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:NakajimaAkira...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:YamakuniTohru...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:NakagawasaiOs...lld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:OmaeNaokiNlld:pubmed
pubmed-article:17895593pubmed:authorpubmed-author:HaraguchiMits...lld:pubmed
pubmed-article:17895593pubmed:issnTypePrintlld:pubmed
pubmed-article:17895593pubmed:volume105lld:pubmed
pubmed-article:17895593pubmed:ownerNLMlld:pubmed
pubmed-article:17895593pubmed:authorsCompleteYlld:pubmed
pubmed-article:17895593pubmed:pagination122-6lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:meshHeadingpubmed-meshheading:17895593...lld:pubmed
pubmed-article:17895593pubmed:year2007lld:pubmed
pubmed-article:17895593pubmed:articleTitleNobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice.lld:pubmed
pubmed-article:17895593pubmed:affiliationDepartment of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.lld:pubmed
pubmed-article:17895593pubmed:publicationTypeJournal Articlelld:pubmed